Clinical Trials List
2022-03-25 - 2026-07-07
Phase III
Not yet recruiting3
Recruiting5
ICD-10C61
Malignant neoplasm of prostate
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9185
Malignant neoplasm of prostate
-
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/14
Investigators and Locations
Co-Principal Investigator
- Che-Yuan Hu 無
- 楊舜如 無
- Jiann-Hui Ou 無
- Wu-Chou Su 無
- Yuh-Shyan Tsai 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 林雁婷醫師 無
- Cheng-Kuang Yang 無
- Cheng-Che Chen 無
- 王樹吉醫師 無
- 張瓈文醫師 無
- 林嘉彥醫師 無
- Chuan-Shu Chen 無
- 張文醫師 未分科
- 賴谷順醫師 無
- 蔡世傳醫師 無
- 洪晟鈞醫師 無
- 裘坤元醫師 無
- 廖博崎醫師 無
- Jian-Ri Li 無
- 盧嘉文醫師 無
- 梅承恩醫師 無
- 胡如娟醫師 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hsi-Chin Wu 無
- Po-Fan Hsieh 無
- Che-Hung Lin 無
- 蔡禮賢 無
- Chao-Hsiang Chang 無
- Ching-Chan Lin 無
- Han Chang 無
- 謝德鈞 無
- Yi-Huei Chang 無
- Wei-Ching Lin 無
- Po-Jen Hsiao 無
- Chi-Rei Yang 無
- Su-Peng Yeh 無
- Yu-De Wang 無
- 賴俊佑 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
1000 participants
